Skip to main content

Table 1 Clinicopathological features of 111 patients of hilar cholangiocarcinoma

From: Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification

 

Resectability by three-dimensional visualization evaluation

Clinicopathological features

Total

Resectable group

Unresectable group

P value

No. of patients

111

80

31

 

Age (years)a

65 ± 10

66 ± 9

62 ± 11

0.053

Sex (M/F)

68/43

51/29

17/14

0.387

Preoperative biliary drainage

20/91

17/63

3/28

0.155

Tumor size(≤ 1/1 ~ 3 cm/ ≥ 3 cm

8/45/58

6/35/39

2/10/19

0.488

Tumor form

   

0.016

 Sclerosing

43

35

8

 

 Mass

50

32

18

 

 Polypoid

9

9

0

 

 Mixed

9

4

5

 

Tumor differentiation (well/moderately/poorly)

3/80/28

2/59/19

1/21/9

0.818

Hepatic artery involvementb

57(52.3%)

34(42.5%)

23(79.3%)

 < 0.001

Portal vein involvementc

55(50.0%)

31(38.6%)

24(80.0%)

 < 0.001

Hepatic vein involvement

5(4.5%)

3(3.8%)

2(6.5%)

0.538

Lymph node metastasisd

54(49.1%)

31(38.8%)

23(76.7%)

 < 0.001

Distant metastasis

5(4.5%)

1(1.3%)

4(12.9%)

0.008

Perineural invasion

56(50.5%)

35(43.8%)

21(67.7%)

0.023

Hepatic lobe atrophy

21(18.9%)

10(12.5%)

11(35.5%)

0.006

Resection status

   

 < 0.001

 R0

71(64.9%)

63(78.8%)

8(25.8%)

 

 R1

15(13.5%)

15(18.8%)

0(0.0%)

 

 R2

7(6.3%)

1(1.2%)

6(19.4%)

 

 Unresectable

18(16.2%)

1(1.2%)

17(54.8%)

 
  1. Data are presented as number (%) or mean ± standard deviation
  2. aData are mean ± standard deviation
  3. b2 cases belonged to unresectable group but lost the information of hepatic arterial involvement
  4. c1 case belonged to unresectable group but lost the information of portal vein involvement
  5. d1 case belonged to unresectable group but lost the information of lymph node metastasis